Tobira Therapeutics Inc (TBRA)-Medical Equipment-Deals and Alliances Profile
- GDME140409D
- Pages: 24
- April 2017
- Total Views:1293
- Region : North America
- GlobalData
- Equity Research Report

Details
Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Evogliptin (EVO). The company's lead product candidate, cenicriviroc, is a proprietary immunomodulator which is used to treat diseases such as HIV-1, and others. Evogliptin is an orally bioavailable, selective dipeptidyl peptidase-4 inhibitor which prevents the breakdown of incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). The company seeks partnership for in-licensing and combination therapy development for the fibrosis, inflammation and HIV. Tobira is headquartered in San Francisco, California, the US.
Tobira Therapeutics Inc (TBRA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tobira Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tobira Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Tobira Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Tobira Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Regado Biosciences Raises US$51 Million In Series E Financing 10
Regado Biosciences Secures US$11.6 Million In Financing 11
Equity Offering 12
Regado Biosciences Completes Public Offering Of Shares For US$60 Million 12
Regado Biosciences Completes Private Placement Of Shares For US$20 Million 13
Regado Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For IPO For US$43 Million 14
Acquisition 15
Allergan Acquires Tobira Therapeutics in Tender Offer 15
Tobira Therapeutics Inc-Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 09, 2016: Tobira Therapeutics Reports Second Quarter 2016 Financial and Business Results 21
May 09, 2016: Tobira Therapeutics Reports First Quarter 2016 Financial and Business Results 22
Mar 03, 2016: Tobira Therapeutics Reports Fourth Quarter 2015 Financial and Year-End Business ResultsC 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List Of Figure
List of Figures
Tobira Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tobira Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tobira Therapeutics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
List Of Table
List of Tables
Tobira Therapeutics Inc, Medical Equipment, Key Facts, 2015 1
Tobira Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tobira Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tobira Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Tobira Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Regado Biosciences Raises US$51 Million In Series E Financing 10
Regado Biosciences Secures US$11.6 Million In Financing 11
Regado Biosciences Completes Public Offering Of Shares For US$60 Million 12
Regado Biosciences Completes Private Placement Of Shares For US$20 Million 13
Regado Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For IPO For US$43 Million 14
Allergan Acquires Tobira Therapeutics in Tender Offer 15
Tobira Therapeutics Inc, Key Competitors 18
Tobira Therapeutics Inc, Key Employees 19
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Company Profile
Company Profile Title
Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Evogliptin (EVO). The company's lead product candidate, cenicriviroc, is a proprietary immunomodulator which is used to treat diseases such as HIV-1, and others. Evogliptin is an orally bioavailable, selective dipeptidyl peptidase-4 inhibitor which prevents the breakdown of incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). The company seeks partnership for in-licensing and combination therapy development for the fibrosis, inflammation and HIV. Tobira is headquartered in San Francisco, California, the US.
Tobira Therapeutics Inc (TBRA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tobira Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tobira Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Tobira Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Tobira Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Regado Biosciences Raises US$51 Million In Series E Financing 10
Regado Biosciences Secures US$11.6 Million In Financing 11
Equity Offering 12
Regado Biosciences Completes Public Offering Of Shares For US$60 Million 12
Regado Biosciences Completes Private Placement Of Shares For US$20 Million 13
Regado Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For IPO For US$43 Million 14
Acquisition 15
Allergan Acquires Tobira Therapeutics in Tender Offer 15
Tobira Therapeutics Inc-Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 09, 2016: Tobira Therapeutics Reports Second Quarter 2016 Financial and Business Results 21
May 09, 2016: Tobira Therapeutics Reports First Quarter 2016 Financial and Business Results 22
Mar 03, 2016: Tobira Therapeutics Reports Fourth Quarter 2015 Financial and Year-End Business ResultsC 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List Of Figure
List of Figures
Tobira Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tobira Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tobira Therapeutics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
List Of Table
List of Tables
Tobira Therapeutics Inc, Medical Equipment, Key Facts, 2015 1
Tobira Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Tobira Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tobira Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Tobira Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tobira Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Tobira Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Regado Biosciences Raises US$51 Million In Series E Financing 10
Regado Biosciences Secures US$11.6 Million In Financing 11
Regado Biosciences Completes Public Offering Of Shares For US$60 Million 12
Regado Biosciences Completes Private Placement Of Shares For US$20 Million 13
Regado Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For IPO For US$43 Million 14
Allergan Acquires Tobira Therapeutics in Tender Offer 15
Tobira Therapeutics Inc, Key Competitors 18
Tobira Therapeutics Inc, Key Employees 19
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company